Receptors, Interleukin-1 Type II
"Receptors, Interleukin-1 Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-1 receptor subtype that competes with the INTERLEUKIN-1 RECEPTOR TYPE I for binding to INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The interleukin-1 type II receptor appears to lack signal transduction capability. Therefore it may act as a "decoy" receptor that modulates the activity of its ligands. Both membrane-bound and soluble forms of the receptor have been identified.
MeSH Number(s)
D12.776.543.750.705.852.420.300.750
D23.050.301.264.035.699
D23.101.100.110.699
Concept/Terms
Receptors, Interleukin-1 Type II- Receptors, Interleukin-1 Type II
- Receptors, Interleukin 1 Type II
- CDw121b Antigens
- Interleukin-1 Receptor, Type 2
- Interleukin 1 Receptor, Type 2
- Interleukin-1 Receptors Type II
- Interleukin 1 Receptors Type II
- Antigens, CDw121b
- Interleukin-1 Receptor Type II
- Interleukin 1 Receptor Type II
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-1 Type II".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Interleukin [D12.776.543.750.705.852.420]
- Receptors, Interleukin-1 [D12.776.543.750.705.852.420.300]
- Receptors, Interleukin-1 Type II [D12.776.543.750.705.852.420.300.750]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, CD [D23.050.301.264.035]
- Receptors, Interleukin-1 Type II [D23.050.301.264.035.699]
- Biological Markers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, CD [D23.101.100.110]
- Receptors, Interleukin-1 Type II [D23.101.100.110.699]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-1 Type II".
This graph shows the total number of publications written about "Receptors, Interleukin-1 Type II" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Interleukin-1 Type II" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
Below are the most recent publications written about "Receptors, Interleukin-1 Type II" by people in Profiles.
-
Prolonged neutrophil survival at necrotic sites is a fundamental feature for tissue recovery and resolution of hepatic inflammation. J Leukoc Biol. 2020 10; 108(4):1199-1213.
-
Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache. Ann Neurol. 2016 06; 79(6):1000-13.
-
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression. Breast Cancer Res. 2012 Mar 09; 14(2):R41.
-
Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea. Inflamm Bowel Dis. 2011 Aug; 17(8):1719-25.
-
Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology. 2010 Jul-Aug; 59(1-2):37-48.
-
Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One. 2009; 4(4):e5293.
-
Potent inhibition of cartilage biosynthesis by coincubation with joint capsule through an IL-1-independent pathway. Scand J Med Sci Sports. 2009 Aug; 19(4):528-35.
-
Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts. J Heart Lung Transplant. 2007 Dec; 26(12):1255-63.
-
Determinants of plasma leptin concentration in postmenopausal women. Mech Ageing Dev. 2004 Feb; 125(2):117-9.
-
Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy. Eur Cytokine Netw. 1999 Mar; 10(1):37-42.